Browsing Tag
PRIALT
1 post
TerSera Therapeutics real-world ziconotide data at ASPN 2025 shows rising guideline-based intrathecal pain therapy adoption
TerSera Therapeutics highlights real-world ziconotide prescribing trends at ASPN 2025, signaling growing guideline-aligned adoption in chronic pain management.
July 19, 2025